Icahn Boosts Stake in Amylin: Look for a Future Sale [View article]
foolish to think that Icahn can do much to expedite the development of diabetic and obesity compounds in Amlyn’s portfolio. He might, however, be more ‘persuasive’ in convincing Bradbury and the board to sell the company to its diabetic partner, Eli Lilly!
Icahn Boosts Stake in Amylin: Look for a Future Sale [View article]
blogs.bnet.com/secdocu...